 Neostigmine
"Neostigmine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
| Descriptor ID |
D009388
|
| MeSH Number(s) |
D02.092.877.674.666 D02.675.276.602
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neostigmine".
Below are MeSH descriptors whose meaning is more specific than "Neostigmine".
This graph shows the total number of publications written about "Neostigmine" by people in this website by year, and whether "Neostigmine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 0 | 1 | 1 | | 2019 | 0 | 1 | 1 | | 2020 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neostigmine" by people in Profiles.
-
Li G, Freundlich RE, Gupta RK, Hayhurst CJ, Le CH, Martin BJ, Shotwell MS, Wanderer JP. Postoperative Pulmonary Complications' Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis. Anesthesiology. 2021 06 01; 134(6):862-873.
-
Krause M, Fernandez-Bustamante A, Bartels K. In Response. Anesth Analg. 2020 08; 131(2):e74-e75.
-
Krause M, Fernandez-Bustamante A, Bartels K. In Response. Anesth Analg. 2020 08; 131(2):e79-e80.
-
Krause M, McWilliams SK, Bullard KJ, Mayes LM, Jameson LC, Mikulich-Gilbertson SK, Fernandez-Bustamante A, Bartels K. Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design. Anesth Analg. 2020 07; 131(1):141-151.
-
Kheterpal S, Vaughn MT, Dubovoy TZ, Shah NJ, Bash LD, Colquhoun DA, Shanks AM, Mathis MR, Soto RG, Bardia A, Bartels K, McCormick PJ, Schonberger RB, Saager L. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis. Anesthesiology. 2020 06; 132(6):1371-1381.
-
Bartels K, Hunter JM. Neostigmine versus sugammadex: the tide may be turning, but we still need to navigate the winds. Br J Anaesth. 2020 05; 124(5):504-507.
-
Banik RK, Karuppiah S, Kaizer AM. Statistical significance versus clinical relevance. Comment on Br J Anaesth 2020; 124: 154-63. Br J Anaesth. 2020 06; 124(6):e227-e228.
-
Naveed M, Jamil LH, Fujii-Lau LL, Al-Haddad M, Buxbaum JL, Fishman DS, Jue TL, Law JK, Lee JK, Qumseya BJ, Sawhney MS, Thosani N, Storm AC, Calderwood AH, Khashab MA, Wani SB. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus. Gastrointest Endosc. 2020 02; 91(2):228-235.
-
Bronsert MR, Henderson WG, Monk TG, Richman JS, Nguyen JD, Sum-Ping JT, Mangione MP, Higley B, Hammermeister KE. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival. Anesth Analg. 2017 05; 124(5):1476-1483.
-
Bulka CM, Terekhov MA, Martin BJ, Dmochowski RR, Hayes RM, Ehrenfeld JM. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia. Anesthesiology. 2016 10; 125(4):647-55.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|